Geneva [Switzerland], January 23 (ANI): The World Health Organization (WHO) on Friday introduced that it had reached an settlement with Pfizer/BioNTech for 40 million doses of their COVID-19 vaccine delivering to poor international locations beneath its COVAX initiative subsequent month.
COVAX is co-led by the World Health Organization and Gavi, the Vaccine Alliance. The Pfizer-BioNTech vaccine had acquired emergency use approval from the WHO.
According to a press launch by WHO, the supply of vaccines to lower-income international locations and assist deliver a fast finish to the acute stage of the COVID-19 pandemic.
COVAX additionally confirmed that it’s going to train an current settlement with the Serum Institute of India (SII) – to obtain its first 100 million doses of the AstraZeneca/Oxford University-developed vaccine manufactured by SII. It anticipates that, through an current settlement with AstraZeneca, 100 million doses of the vaccine can be obtainable for supply within the first quarter of the 12 months, the discharge mentioned.
“Today marks another milestone for COVAX: pending regulatory approval for the AstraZeneca/Oxford candidate and pending the successful conclusion of the supply agreement for the Pfizer-BioNTech vaccine, we anticipate being able to begin deliveries of life-saving COVID-19 vaccines by the end of February,” mentioned Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, which leads COVAX procurement and supply.
“This is not just significant for COVAX, it is a major step forward for equitable access to vaccines, and an essential part of the global effort to beat this pandemic. We will only be safe anywhere if we are safe everywhere,” Berkley added.
“The urgent and equitable rollout of vaccines is not just a moral imperative, it’s also a health security, strategic and economic imperative,” mentioned Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.
Tedros additional said, “This agreement with Pfizer will help to enable COVAX to save lives, stabilize health systems and drive the global economic recovery.”
“These purchase agreements open the door for these lifesaving vaccines to become available to people in the most vulnerable countries,” mentioned UNICEF Executive Director Henrietta Fore.
“But at the same time we are securing vaccines we must also ensure that countries are ready to receive them, deploy them, and build trust in them,” Fore mentioned additional.
The COVAX Facility intends to supply all 190 collaborating economies with an indicative allocation of doses by the tip of this month, the discharge mentioned.
Follow us on Google News